CHRONIC MYELOID LEUKAEMIA TRANSFORMATION

This adverse event was reported 446 times

These drugs are most commonly taken by patients reporting CHRONIC MYELOID LEUKAEMIA TRANSFORMATION:

# Drug Count
0 NILOTINIB 130
1 IMATINIB 56
2 DASATINIB 53
3 IMATINIB MESYLATE 44
4 PONATINIB HYDROCHLORIDE 34
5 ASCIMINIB 20
6 CYTARABINE 20
7 HYDROXYUREA 20
8 ALLOPURINOL 13
9 BOSUTINIB 12
See all common drugs associated with CHRONIC MYELOID LEUKAEMIA TRANSFORMATION

CHRONIC MYELOID LEUKAEMIA TRANSFORMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PONATINIB HYDROCHLORIDE 34 0.0065
1 ASCIMINIB 20 0.0057
2 DASATINIB 53 0.0057
3 NILOTINIB 130 0.0044
4 IMATINIB MESYLATE 44 0.0016
5 BOSUTINIB 12 0.0013
6 ROPEGINTERFERON ALFA-2B 2 0.0011
7 HYDROXYUREA 20 0.0009
8 MEPIVACAINE HYDROCHLORIDE 1 0.0009
9 TELMISARTAN AND HYDROCHLOROTHIAZIDE 2 0.0008
See all drugs enriched for association with CHRONIC MYELOID LEUKAEMIA TRANSFORMATION